Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and openWorldHint=false, so the safety profile is covered. The description adds useful behavioral detail beyond that: the result is exhaustive across all diseases, ordered alphabetically, and each entry carries several distinct data categories. It does not disclose result size or cost, which for an 'every disease' listing is a minor gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two dense sentences with no filler. The scope and payload listing come first, the routing guidance second, which is the right front-loading order for an agent deciding whether to call this.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Zero parameters, full annotation coverage, and an output schema that carries return-value detail. The description supplies exactly the missing pieces: what the list spans, how it is ordered, and which tools to use next.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The tool takes zero parameters, so there are no semantics to communicate; the baseline for a parameter-less tool is 4. The description correctly implies no input is required.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (LIST) and resource (every disease bench in the lab), then enumerates the payload contents: trials, open trials, mapping coverage, ledger claims, results-gap work and readiness gates per disease. The single-bench counterpart get_lab_module is named as a separate tool, so an agent can distinguish the two without opening schemas.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly routes the agent: use get_lab_module for one disease, then next_results_gap_trial with that disease id. That is a clear condition for the alternative, though it never states when NOT to call this tool (e.g., if you already know the disease id, skip straight to get_lab_module).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.